Bill Doyle: Treating cancer with electric fields
บิวล์ ลอยล์: ดูแลรักษามะเร็งด้วยสนามไฟฟ้า
With his company Novocure, Bill Doyle works to bring breakthrough medical technologies to doctors and patients. Full bio
Double-click the English transcript below to play the video.
(Tumor Treating Fields)
ที่อยู่ภายนอกร่างกาย
(Tumor Treating Fields)
และเนื้องอกก็กลับมาเติบโตอีกครั้ง
(Tumor Treating Fields)
(Tumor Treating Fields)
(Tumor Treating Fields)
(FDA) รับรองการรักษาเนื้องอกเฉพาะที่
การรักษาเนื้องอกเฉพาะที่
ของการส่งเสริมซึ่งกันและกัน
จะทำงานกับการฉายแสงได้
ABOUT THE SPEAKER
Bill Doyle - EngineerWith his company Novocure, Bill Doyle works to bring breakthrough medical technologies to doctors and patients.
Why you should listen
Bill Doyle is the executive chair of Novocure, a company commercializing a new therapeutic modality for solid tumors using low-intensity electric fields. Recently, Novocure received FDA approval for its first indication, recurrent Glioblastoma Multiforme (GBM), the most virulent form of brain cancer; it is now conducting additional clinical trials.
In 2002, Doyle co-founded medical device venture firm WFD Ventures, which provides financing and business-building expertise to medical device companies with the potential to make a major impact on patient care, working with entrepreneurs, doctors and scientists to improve medical outcomes and maximize the potential of their innovations.
A graduate of MIT, Doyle stablished the MIT FIRST Scholarship for FIRST Robotics Competition participants admitted to MIT.
Watch Jay Walker's onstage Q&A with Bill Doyle >>
Bill Doyle | Speaker | TED.com